Tensor Contraction Engine

Neuvotion Secures an Additional $1.25M to Commercialize NeuStim™ Technology for Treating Stroke and Debilitating Injuries

Retrieved on: 
Thursday, April 13, 2023
Disability studies, Feinstein Institutes for Medical Research, Stroke, Tensor Contraction Engine, PT, Rehabilitation, Patient, CEM, FDA, Northwell Health, MHA, Medical research, IPS, Injury, Medical device

Northwell Holdings, the venture investment arm of Northwell Health, Topspin Fund, and Long Island Angel Network also participated in the round.

Key Points: 
  • Northwell Holdings, the venture investment arm of Northwell Health, Topspin Fund, and Long Island Angel Network also participated in the round.
  • This funding will be used by Neuvotion to further expand its team, complete clinical studies, and obtain FDA clearance for its initial product.
  • Neuvotion is also proud to continue their work with Intelligent Product Solutions (IPS) and Contract Engineering and Manufacturing (CEM) to bring Neuvotion's products to market.
  • "This technology has the potential to open new doors to regained independence and recovery for those facing difficult neurological conditions and injuries."